Have a personal or library account? Click to login
Cag Repeat Number in the Androgen Receptor Gene and Prostate Cancer Cover

Cag Repeat Number in the Androgen Receptor Gene and Prostate Cancer

Balkan Journal of Medical Genetics
Volume 15 (2012): Issue 1 (June 2012)
By: S Madjunkova,  A Eftimov,  V Georgiev,  D Petrovski,  A Dimovski and  D Plaseska-Karanfilska  
Open Access
|Jul 2012

References

  1. Crawford ED. Epidemiology of prostate cancer. Urology. 2003; 62(6): 3-12.10.1016/j.urology.2003.10.013
    Search in Google Scholar
  2. Gronberg H. Prostate cancer epidemiology. Lancet. 2003; 361(9360): 859-864.10.1016/S0140-6736(03)12713-4
    Search in Google Scholar
  3. Haas GP, Sakr WA. Epidemiology of prostate cancer. CA Cancer J Clin. 1997; 47(5): 273-287.10.3322/canjclin.47.5.273
    Search in Google Scholar
  4. Scosyrev E, Messing EM, Mohile S, Golijanin D, Wu G. Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality. Cancer. 2011; doi: 10.1002/cncr.26392. [Epub ahead of print].10.1002/cncr.26392
    Search in Google Scholar
  5. Nelson KA, Witte JS. Androgen receptor CAG repeats and prostate cancer. Am J Epidemiol. 2002; 155(10): 883-890.10.1093/aje/155.10.883
    Search in Google Scholar
  6. Mittal RD, Mishra D, Mandhani AK. Role of an an drogen receptor gene polymorphism in development of hormone refractory prostate cancer in Indian population. Asian Pac J Cancer Prev. 2007; 8(2): 275-278.
    Search in Google Scholar
  7. Cotter MP, Gern RW, Ho GY, Chang RY, Burk RD. Role of family history and ethnicity on the mode and age of prostate cancer presentation. Prostate. 2002; 50(4): 216-221.10.1002/pros.10051
    Search in Google Scholar
  8. Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer. 2006; 106(6): 1276-1285.10.1002/cncr.21732
    Search in Google Scholar
  9. Schaid DJ. The complex genetic epidemiology of prostate cancer. Hum Mol Genet. 2004; 13(Spec No 1): R103-121.10.1093/hmg/ddh072
    Search in Google Scholar
  10. Feldman BJ, Feldman D. The development of andro gen-independent prostate cancer. Nat Rev Cancer. 2001; 1(1): 34-45.10.1038/35094009
    Search in Google Scholar
  11. Lu S, Tsai SY, Tsai MJ. Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. Cancer Res. 1997; 57(20): 4511-4516.
    Search in Google Scholar
  12. Montgomery JS, Price DK, Figg WD. The androgen receptor gene and its influence on the development and progression of prostate cancer. J Pathol. 2001; 195(2): 138-146.10.1002/1096-9896(200109)195:2<;138::AID-PATH961>3.0.CO;2-Y
    Search in Google Scholar
  13. Edwards A, Hammond HA, Jin L, Caskey CT, Chakraborty R. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics. 1992; 12(2): 241-253.10.1016/0888-7543(92)90371-X
    Search in Google Scholar
  14. Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Dahl D, Brufsky A, Talcott J, Hennekens CH, Kantoff PW. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA. 1997; 94(7): 3320-3323.10.1073/pnas.94.7.3320203679096391
    Search in Google Scholar
  15. Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 1994; 22(15): 3181-3186.10.1093/nar/22.15.31813102948065934
    Search in Google Scholar
  16. Hardy DO, Scher HI, Bogenreider T, Sabbatini P, Zhang ZF, Nanus DM, Catterall JF. Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. J Clin Endocrinol Metab. 1996; 81(12): 4400-4405.
    Search in Google Scholar
  17. Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal CL, Blumenstein BA, Ostrander EA. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res. 1997; 57(6): 1194-1198.
    Search in Google Scholar
  18. Irvine RA, Yu MC, Ross RK, Coetzee GA. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res. 1995; 55(9): 1937-1940.
    Search in Google Scholar
  19. Zeegers MP, Kiemeney LA, Nieder AM, Ostrer H. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk? Cancer Epidemiol Biomarkers Prev. 2004; 13(11): 1765-1771.10.1158/1055-9965.1765.13.11
    Search in Google Scholar
  20. Price DK, Chau CH, Till C, Goodman PJ, Baum CE, Ockers SB, English BC, Minasian L, Parnes HL, Hsing AW, Reichardt JK, Hoque A, Tangen CM, Kristal AR, Thompson IM, Figg WD. Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial. J Urol. 2010; 184(6): 2297-2302.10.1016/j.juro.2010.08.005393017520952028
    Search in Google Scholar
  21. Lindstrom S, Ma J, Altshuler D, Giovannucci E, Riboli E, Albanes D, Allen NE, Berndt SI, Boeing H, Bueno-de-Mesquita HB, Chanock SJ, Dunning AM, Feigelson HS, Gaziano JM, Haiman CA, Hayes RB, Henderson BE, Hunter DJ, Kaaks R, Kolonel LN, Le Marchand L, Martinez C, Overvad K, Siddiq A, Stampfer M, Stattin P, Stram DO, Thun MJ, Trichopoulos D, Tumino R, Virtamo J, Weinstein SJ, Yeager M, Kraft P, Freedman ML. A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. J Clin Endocrinol Metab. 2010; 95(9): E121-E127.10.1210/jc.2009-1911293607520534771
    Search in Google Scholar
  22. Mishra D, Thangaraj K, Mandhani A, Kumar A, Mittal R. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population? Clin Genet. 2005; 68(1): 55-60.10.1111/j.1399-0004.2005.00450.x15952987
    Search in Google Scholar
  23. Hakimi JM, Schoenberg MP, Rondinelli RH, Piantadosi S, Barrack ER. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin Cancer Res. 1997; 3(9): 1599-1608.
    Search in Google Scholar
  24. Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL, Sesterhenn IA, Mostofi FK, Benichou J, Chang C. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Res. 2000; 60(18): 5111-5116.
    Search in Google Scholar
  25. Akinloye O, Gromoll J, Simoni M. Variation in CAG and GGN repeat lengths and CAG/GGN haplotype in androgen receptor gene polymorphism and prostate carcinoma in Nigerians. Br J Biomed Sci. 2011; 68(3): 138-142.10.1080/09674845.2011.1173034121950206
    Search in Google Scholar
  26. Plaseski T, Noveski P, Dimitrovski C, Kocevska B, Efremov GD, Plaseska-Karanfilska D. CAG Repeat number in androgen receptor gene and male infertility. BJMG. 2007; 10(1): 19-24.10.2478/v10034-007-0003-8
    Search in Google Scholar
  27. Coetzee GA, Ross RK. Re: prostate cancer and the androgen receptor. J Natl Cancer Inst. 1994; 86(11): 872-873.10.1093/jnci/86.11.8728182772
    Search in Google Scholar
  28. Ding D, Xu L, Menon M, Reddy GP, Barrack ER. Effect of a short CAG (glutamine) repeat on human androgen receptor function. Prostate. 2004; 58(1): 23-32.10.1002/pros.1031614673949
    Search in Google Scholar
  29. Gu M, Dong X, Zhang X, Niu W. The CAG repeat polymorphism of androgen receptor gene and prostate cancer: a meta-analysis. Mol Biol Rep. 2011; 39(3): 2615-2624.10.1007/s11033-011-1014-9
    Search in Google Scholar
  30. Binnie MC, Alexander FE, Heald C, Habib FK. Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer. Prostate. 2005; 63(4): 309-315.10.1002/pros.20178
    Search in Google Scholar
  31. Correa-Cerro L, Wohr G, Haussler J, Berthon P, Drelon E, Mangin P, Fournier G, Cussenot O, Kraus P, Just W, Paiss T, Cantu JM, Vogel W. (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population. Eur J Hum Genet. 1999; 7(3): 357-362.10.1038/sj.ejhg.5200298
    Search in Google Scholar
  32. Salinas CA, Austin MA, Ostrander EO, Stanford JL. Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk. Prostate. 2005; 65(1): 58-65.10.1002/pros.20230
    Search in Google Scholar
  33. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010; 60(5): 277-300.10.3322/caac.20073
    Search in Google Scholar
  34. Polednak AP. Trends in prostate carcinoma inci dence in Connecticut (1988-1994) by age and race. Cancer. 1997; 79(1): 99-103.10.1002/(SICI)1097-0142(19970101)79:1<;99::AID-CNCR14>3.0.CO;2-1
    Search in Google Scholar
  35. Rodriguez-Gonzalez G, Cabrera S, Ramirez-Moreno R, Bilbao C, Diaz-Chico JC, Serra L, Chesa N, Cabrera JJ, Diaz-Chico BN. Short alleles of both GGN and CAG repeats at the exon-1 of the androgen receptor gene are associated to increased PSA staining and a higher Gleason score in human prostatic cancer. J Steroid Biochem Mol Biol. 2009; 113(1-2): 85-91.10.1016/j.jsbmb.2008.11.010
    Search in Google Scholar
  36. Platz EA, Giovannucci E, Dahl DM, Krithivas K, Hennekens CH, Brown M, Stampfer MJ, Kantoff PW. The androgen receptor gene GGN microsatellite and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 1998; 7(5): 379-384.
    Search in Google Scholar
  37. Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ, Willett WC, Giovannucci E. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Cancer Epidemiol Biomarkers Prev. 2005; 14(5): 1262-1269.10.1158/1055-9965.EPI-04-0371
    Search in Google Scholar
  38. Bousema JT, Bussemakers MJ, van Houwelingen KP, Debruyne FM, Verbeek AL, de La Rosette JJ, Kiemeney LA. Polymorphisms in the vitamin D receptor gene and the androgen receptor gene and the risk of benign prostatic hyperplasia. Eur Urol. 2000; 37(2): 234-238.10.1159/000020124
    Search in Google Scholar
  39. Kristal AR, Price DK, Till C, Schenk JM, Neuhouser ML, Ockers S, Lin DW, Thompson IM, Figg WD. Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. Prostate. 2010; 70(6): 584-590.10.1002/pros.21092
    Search in Google Scholar
  40. Gsur A, Preyer M, Haidinger G, Zidek T, Madersbacher S, Schatzl G, Marberger M, Vutuc C, Micksche M. Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk. Carcinogenesis. 2002; 23(10): 1647-1651.10.1093/carcin/23.10.164712376473
    Search in Google Scholar
DOI: https://doi.org/10.2478/v10034-012-0005-z | Journal eISSN: 2199-5761
Journal RSS Feed
Language: English
Page range: 31 - 36
Published on: Jul 20, 2012
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Prostrate cancer (PC),
Androgen receptor (AR) gene,
CAG repeat,
Benign prostatic hyperplasia (BPH)
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2012 S Madjunkova, A Eftimov, V Georgiev, D Petrovski, A Dimovski, D Plaseska-Karanfilska, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons License.

Volume 15 (2012): Issue 1 (June 2012)